Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Chronic Kidney Disease: full-pipeline trial registry
32 of 103 indexed Chronic Kidney Disease trials are currently recruiting.
Corpus placement: #130 of 28,707 conditions by registered trial count.
103 US clinical trials · 32 currently recruiting · #130 of 28,707 conditions by registered trial count
Chronic Kidney Disease: 103 US clinical trials tracked, 32 recruiting.
Chronic Kidney Disease is the subject of 103 registered US clinical trials on ClinicalTrials.gov, 32 of them currently open to new participants. 27 are in Phase 3-4 (later-stage) and 27 in Phase 1-2 (earlier-stage). The most active sponsor is Bayer, running 8 of these trials.
Enrollment posture brief
Registry condition chronic-kidney-disease
OPEN 32 | RECR 31% | LATE 27 | EARLY 27 | RANK #130 | SPON 8
Volume-matched condition peers
Nearest open-share peer: Eosinophilic Esophagitis (31% recruiting · 45 trials)
Chronic Kidney Disease lists 32 open slots (31% of 103 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Chronic Kidney Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Chronic Kidney Disease is recruiting below its size-band peers.
32 of 103 indexed trials (31.1%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Chronic Kidney Disease trials is spread across many organizations.
Bayer accounts for 8 of 103 trials (7.8%). 68 distinct sponsors appear on at least one study for this condition label.
-
Typical Chronic Kidney Disease enrolment sits around 124 participants.
Median target enrolment is 124 among the 102 trials that report a genuine target (sentinel values excluded). 43 of those (42.2%) plan for fewer than 100 participants.
-
Chronic Kidney Disease research is mostly interventional.
82 interventional and 21 observational studies make up this index (79.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
103 total, page 3 of 3
Safety, Tolerability, and Pharmacokinetics of KBP-5074 Following Oral Administration in Chronic Kidney Disease
KBP Biosciences
NCT02837237
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
Massachusetts General Hospital
NCT01758042
The Effect of Administration on N-Acetylcysteine on Serum Creatinine Levels in Patients With Chronic Kidney Disease
University of Vermont
NCT00498342
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 10 |
| Phase 2 | 17 |
| Phase 3 | 19 |
| Phase 4 | 8 |
Top Sponsors
Named interventions
Most-linked intervention names on Chronic Kidney Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Chronic Kidney Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Chronic Kidney Disease page
103 registered trials, 32 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 32 Chronic Kidney Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Bayer sponsors the most Chronic Kidney Disease trials on record, review their full trial history before evaluating a specific study. See Bayer's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chronic Kidney Disease condition card totals 103 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.